High Court Won't Hear FDA Stem Cell Regulation Fight
By Gianna Ferrarin · October 14, 2025, 9:52 AM EDT
The U.S. Supreme Court on Tuesday declined to review a circuit court holding that a stem cell treatment derived from a patient's own tissue is subject to Food, Drug and Cosmetic Act...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login